<DOC>
	<DOCNO>NCT01031186</DOCNO>
	<brief_summary>This study evaluate safety , tolerability , pharmacokinetics GSK356278 male volunteer</brief_summary>
	<brief_title>First Time Human Study</brief_title>
	<detailed_description>To evaluate safety , tolerability pharmacokinetics single ascend dos GSK356278 may assess effect food GSK356278 pharmacokinetics . They study assess compound 's effect nausea , emesis alertness . Close monitoring cardiovascular parameter include .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>AST , ALT , alkaline phosphate bilirubin less equal 1.5 time upper limit normal . Healthy determine responsible experienced physician base medical evaluation include medical history , physical examination , laboratory test cardiac monitoring . Males age 18 65 year inclusive time signing informed consent . Males must agree appropriate form contraception administration first dose 3 month take final dose . Body weight great equal 50 kg BMI within range 1829.9 m2 ( inclusive ) Capable give write informed consent . QTcB QTcF le 450 msec A positive prestudy Hep B positive Hep C result within 3 month screen . Current chronic history liver disease know hepatic biliary abnormality A positive prestudy alcohol drug screen A positive test HIV antibody . History regular alcohol consumption within 6 month study define average weekly intake great 21 unit average daily intake great 3 unit The subject participate clinical trial receive investigational product within time period 30 day prior first dose day ( 5 halflives twice duration biological effect drug , whichever long ) Exposure 4 new chemical entity last 12 month prior first dose day Use prescription nonprescription drug include vitamin , herbal dietary supplement within 7 day ( 14 day drug potential enzyme inducer ) 5 halflives ( whichever longer ) prior first dose unless opinion investigator medical monitor medication interfere study procedure compromise subject safety . History sensitivity study medication history drug allergy opinion investigator medical monitor contraindicate participation . Where participation study would result donation blood blood product excess 500 ml within 56 day period . Unwillingness inability follow procedure protocol . Subject mentally legally incapacitate . Subjects asthma history asthma . Urinary cotinine level indicative smoke history regular use tobacco nicotine containing product within 6 month prior screen . Consumption red wine , seville orange , grapefruit grapefruit juice and/or pummelo , exotic citrus fruit , grapefruit hybrid fruit juices 7 day prior first dose . History significant psychiatric illness . Any history suicidal behaviour suicidal ideation type 4 5 Columbia Suicide Severity Rating Scale last 6 month . History presence clinically significant cardiac arrhythmia clinically significant cardiac disease .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>healthy male volunteer</keyword>
	<keyword>GSK356278</keyword>
	<keyword>first time man</keyword>
	<keyword>major depressive disorder</keyword>
</DOC>